about
ASIC1a Deficient Mice Show Unaltered Neurodegeneration in the Subacute MPTP Model of Parkinson Disease.Therapeutic potential of autophagy-enhancing agents in Parkinson's disease.199 years of Parkinson disease - what have we learned and what is the path to the future?Protein aggregation into insoluble deposits protects from oxidative stress.Current understanding of the molecular mechanisms in Parkinson's disease: Targets for potential treatments.Neuroprotective effects of the gliopeptide ODN in an in vivo model of Parkinson's disease.Carnosic Acid as a Promising Agent in Protecting Mitochondria of Brain Cells.An adverse outcome pathway for parkinsonian motor deficits associated with mitochondrial complex I inhibition.
P2860
Q36184308-E0A4094D-089E-4777-8CE5-3678141ECDD0Q38765856-A957EC22-4991-443E-AE63-7EF599041164Q38825770-045A1BF9-E47D-49D6-9250-1051548C9552Q42291713-0F5213E0-5546-4703-9470-254D27817C61Q45873810-BB3ADA04-1A0A-4E96-B3FE-181EF9C4515BQ47267653-7F3223DD-EADF-4B9D-8A00-8B56D8ED43E1Q47863411-C3B0CDA3-6907-41EB-A2B5-5F2D03370BC3Q48171351-0AADD777-CD9B-4D63-BD27-F2C325AF2523
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Molecular changes in the postmortem parkinsonian brain.
@en
type
label
Molecular changes in the postmortem parkinsonian brain.
@en
prefLabel
Molecular changes in the postmortem parkinsonian brain.
@en
P2860
P356
P1476
Molecular changes in the postmortem parkinsonian brain.
@en
P2093
Damien Toulorge
Rodolphe Hajj
P2860
P356
10.1111/JNC.13696
P407
P478
139 Suppl 1
P577
2016-07-05T00:00:00Z